These mutations are also detected in grade IV glioblastoma (GBM), referred to as IDH1 mutant GBM, which account for ~10% of all grade IV clinical cases but are absent in pediatric high-grade malignancies and in nonglial subtypes of brain tumors [19]. The gene discussed is IDH1; the disease is brain neoplasm.